Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

4.1K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.1K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

2.2K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.2K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

3.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

4.2K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.2K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

700
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
700

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Testosterone level in male patients with coronary heart disease and essential hypertension].

Problemy endokrinologii·2019
Same authorSame journal

[THE HISTORY OF DEPARTMENT OF FACULTY THERAPY, AT THE VORONEZH HIGHER EDUCATION INSTITUTION (ON THE OCCASION OF THE CENTENARY ANNIVERSARY OF N.N. BURDENKO VORONEZH STATE MEDICAL UNIVERSITY)].

Klinicheskaia meditsina·2018
Same author

[CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ANEMIA: CLINICAL MANIFESTATIONS AND THERAPEUTIC STRATEGY].

Klinicheskaia meditsina·2018
Same author

[Clinical manifestations of asthma during combination therapy using ceruloplasmin].

Terapevticheskii arkhiv·2016
Same author

[ANTIOXIDANT THERAPY OF BRONCHIAL ASTHMA].

Klinicheskaia meditsina·2015
Same author

[The diagnostic value of systemic inflammation biomarkers in chronic obstructive pulmonary disease].

Klinicheskaia meditsina·2015

Related Experiment Video

Updated: Apr 8, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

6.0K

[PROINFLAMMATORY CYTOKINES IN COMBINATION OF CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE].

V M Provotorov, A V Budnevskiĭ, G G Semenkova

    Klinicheskaia Meditsina
    |June 30, 2015
    PubMed
    Summary

    Chronic obstructive pulmonary disease (COPD) and coronary heart disease (CHD) often coexist. Systemic inflammation in COPD drives CHD development, worsening atherosclerosis and its complications.

    More Related Videos

    Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
    04:45

    Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

    Published on: June 2, 2022

    2.9K
    A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
    08:33

    A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

    Published on: December 15, 2014

    12.2K

    Related Experiment Videos

    Last Updated: Apr 8, 2026

    Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
    10:03

    Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

    Published on: January 28, 2020

    6.0K
    Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome
    04:45

    Mouse Model of Oleic Acid-Induced Acute Respiratory Distress Syndrome

    Published on: June 2, 2022

    2.9K
    A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
    08:33

    A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide

    Published on: December 15, 2014

    12.2K

    Area of Science:

    • Cardiology
    • Pulmonology
    • Inflammation Research

    Context:

    • Chronic obstructive pulmonary disease (COPD) and coronary heart disease (CHD) frequently present as comorbidities.
    • Systemic inflammation is a key factor linking COPD and cardiovascular disease progression.

    Purpose:

    • To elucidate the pathogenetic role of systemic inflammation in the combined occurrence of COPD and CHD.
    • To investigate the association between inflammatory markers and the deterioration of atherosclerosis and CHD progression.

    Summary:

    • Protracted COPD is associated with systemic inflammation, which acts as the primary pathogenetic mechanism for concurrent coronary heart disease.
    • Elevated systemic inflammation markers correlate significantly with advanced atherosclerosis, increased complications, and accelerated CHD progression.

    Impact:

    • Highlights the critical role of systemic inflammation in the pathophysiology of combined COPD and CHD.
    • Provides insights into potential therapeutic targets for managing cardiovascular risk in COPD patients.